Press Release
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
Explore our News & Stories
Stay up to date with helpful information, announcements, and trending topics.
MORE HEALTH
„Medical innovations and healthcare for everyone“
African Americans are often excluded from healthcare options and underrepresented in clinical trials. We want to better serve them.
Company Culture
"To join Boehringer Ingelheim was the best ever decision"
Pharmacologist Michael Mark worked for us for 34 years and enjoyed every minute. “Watch our video and discover our job opportunities.“
Science Stories
New cancer research building: Boosting innovation in oncology
Learn why we keep on investing in cancer research and how we collaborate with our partners.
Livestock
Biosecurity in farms: what’s this all about?
Discover the essence of biosecurity and how it enhances animal health and livestock productivity.
Our Responsibility
A global production network against supply shortages
How we align our production capacity to the needs of patients.
